JNJON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Ime in priimekJNJON

UvrstitevNo.3622

Tržna kapitalizacija$0,00

Popolnoma razredčena tržna kapitalizacija$0,00

Tržni delež%

Volumen trgovanja/tržna kapitalizacija (24h)14 340 110,61%

Razpoložljivi obtok5,8619757

Največja ponudba0

Skupna ponudba66,51526528

Hitrost kroženja%

Datum izdaje--

Cena, po kateri je bilo sredstvo prvič izdano--

Najvišja vrednost vseh časov250.607309426007,2026-03-02

Najnižja cena203.9667432969526,2026-01-09

Javna veriga blokovETH

UvodJohnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Panoga

Družbeni mediji

• Uradna spletna stran
• Raziskovalec blokov

etfindex:mc_etfindex_sourceOmejitev odgovornosti: Podatke zagotavlja cmc in se ne smejo obravnavati kot naložbeni nasveti.